Skip to main content

Table 2 Details of confirmed fetal CNVs with positive and negative NIPS results

From: Identification of copy number variations among fetuses with isolated ultrasound soft markers in pregnant women not of advanced maternal age

Sample number

Maternal age

Gestational age-weeks

USM

Maternal serum screening

hg19 co-ordinates (NIPS)

Type

Size

Z-score of CNV

Confirmatory method

Confirmatory results

ACMG Classification

Inherited or de novo

Agreement with NIPS

Outcomes

14

31

23 +4

EIF

Low-risk

trisomy13

trisomy

CNV-seq

delXp21.1 (0.32 Mb)

P

NA

Discordant

TOP

38

32

22 +4

EIF

Low-risk

chr13:51500000–55999999

Dup

4.5 Mb

2.25

CNV-seq

del15q11.2 (0.36 Mb)

P

NA

Discordant

TOP

39

30

17 +4

EIF

NA

chr16:15500000–17999999

Del

2.5 Mb

− 9.22

CNV-seq

del16p13.11p12.3 (2.66 Mb)

P

NA

Concordant

TOP

40

29

23 +4

EIF

Low-risk

chr16:15500000–18499999

Dup

3.0 Mb

7.14

CMA

del16p13.11p12.3

P

NA

Concordant

TOP

41

29

17 +6

ARSA

NA

chr10:49500000–52499999

Del

3.0 Mb

− 9.95

CNV-seq

del2q37.3 (4.29 Mb) del10q11.22q11.23 (2.57 Mb)

P/VUS

de novo/Mat

Partially concordant

Birth with defects:congenital anorectal malformation, congenital heart disease, mild ventriculomegaly

42

21

24

EIF

NA

chr5:101500000–110999999

Dup

9.5 Mb

8.96

CNV-seq

dup5q21.1q22.1 (9.11 Mb)

VUS

Mat

Concordant

TOP

43

32

23 +3

EIF

Low-risk

chr13:88500000–91999999

Del

3.5 Mb

− 7.54

CNV-seq

del13q31.2q31.3 (2.54 Mb)

VUS

NA

Concordant

Neonates with no phenotypical abnormalities

44

27

25

EIF

NA

chr8:3500000–6999999

Dup

3.5 Mb

6.22

CNV-seq

dup8p23.2 (2.34 Mb)

VUS

Mat

Concordant

Neonates with no phenotypical abnormalities

45

31

22 +3

EIF

Low-risk

chr3:0–2499999

Dup

2.5 Mb

7.24

CNV-seq

dup3p26.3 (1.44 Mb)

VUS

NA

Concordant

Neonates with no phenotypical abnormalities

46

25

26 +6

EIF

Low-risk

chr1:100000000–105999999

Dup

6.0 Mb

2.07

CNV-seq

dup1p21.2p21.1 (7.18 Mb)

VUS

NA

Concordant

Neonates with no phenotypical abnormalities

47

24

23 +2

EIF

Low-risk

chr2:78500000–80499999

Dup

2.0 Mb

8.13

CNV-seq

dup2p12 (1.68 Mb)

VUS

Mat

Concordant

Neonates with no phenotypical abnormalities

48

29

27

EIF

Low-risk

chr3:0–3499999

Dup

3.5 Mb

2.73

CMA

dup3p26.3p26.2 (3.24 Mb)

VUS

NA

Concordant

Neonates with no phenotypical abnormalities

49

27

24 +5

EIF

Low-risk

chr8:1500000–3999999

Dup

2.5 Mb

4.98

CNV-seq

dup8p23.3p23.2 (2.26 Mb)

VUS

Mat

Concordant

Neonates with no phenotypical abnormalities

50

25

25 +1

EIF

NA

chr9:116500000–118999999

Dup

2.5 Mb

5.33

CNV-seq

dup9q32q33.1 (1.42 Mb)

VUS

Mat

Concordant

Neonates with no phenotypical abnormalities

51

25

24 +2

EIF

Low-risk

chr5:124500000–126499999

Dup

2.0 Mb

6.45

CNV-seq

dup5q23.2q23.2 (1.25 Mb)

VUS

NA

Concordant

Neonates with no phenotypical abnormalities

52

23

21

EIF

Low-risk

chr4:188500000–190999999 chr9:120000000–124499999

Del, Del

2.5 Mb,4.5 Mb

− 5.65, − 6.42

CMA

del4q35.2, del9q33.1

VUS

NA

Concordant

Neonates with no phenotypical abnormalities

53

32

25 +5

EIF

Low-risk

chr6:120500000–122499999

Del

2.0 Mb

− 6.94

CNV-seq

del6q22.31 (1.34 Mb)

VUS

Mat

Concordant

Neonates with no phenotypical abnormalities

54

24

25

EIF

Low-risk

chr21:44000000–46499999

Dup

2.5 Mb

5.83

CNV-seq

dup21q22.3 (2.58 Mb)

VUS

Mat

Concordant

Neonates with no phenotypical abnormalities

55

29

23 +6

EIF

NA

chr21:42000000–43999999

Dup

2.0 Mb

7.47

CNV-seq

dup21q22.2q22.3 (1.56 Mb)

VUS

NA

Concordant

Neonates with no phenotypical abnormalities

56

33

18

CPCs

Low-risk

chr14:25000000–26999999

Dup

2.0 Mb

8.22

CMA

dup14q12

VUS

Mat

Concordant

Neonates with no phenotypical abnormalities

57

26

23

EIF, Mild pyelectasis

Low-risk

chr10:2000000–4499999

Dup

2.5 Mb

6.06

CNV-seq

dup10p15.3p15.2 (1.32 Mb)

VUS

Mat

Concordant

Neonates with no phenotypical abnormalities

58

34

25 +1

SUA

Low-risk

chr18:0–10999999 chr18:29500000–58499999

Del, Dup

11.0 Mb, 29.0 Mb

− 1.49, 1.12

CNV-seq

dup18p11.22p11.21 (1.8 Mb), dup18q12.1q12.1 (1.32 Mb), dup18q21.33q22.1 (4.9 Mb)

VUS

NA

Partially concordant

TOP

59

29

25 +5

EICF

Low-risk

chr2:105000000–106999999

Del

2.0 Mb

− 5.45

CMA

del2q12.1q12.2

VUS

Mat

Concordant

TOP

60

29

25 +1

ARSA

Low-risk

CMA

del16p11.2 (0.60 Mb)

P

NA

Discordant

TOP

61

28

16 +6

Mild ventriculomegaly

NA

CMA

del12q15q22 (26 Mb)

VUS

NA

Discordant

Birth with moderate ventriculomegaly

62

32

17

SUA

NA

CMA

dup5q21.3 (1.43 Mb)

VUS

NA

Discordant

Birth with mild ventriculomegaly

  1. NIPS noninvasive prenatal screening, USM ultrasound soft marker, CNV copy number variant, ACMG American College of Medical Genetics and Genomics, EIF echogenic intracardiac focus, CPCs choroid plexus cysts, SUA single umbilical artery, ARSA aberrant right subclavian artery, CMA Chromosomal microarray, P pathogenic, VUS variant of uncertain significance, Mat maternal, TOP termination of pregnancy, NA not applicable